2026 data Public-data reference. official source

Stent, Ureteral

Open-data reference.

FDA MAUDE adverse event data · 1993–2026

What the Data Shows About Stent, Ureteral

The FDA MAUDE database aggregates 5,594 adverse-event reports for Stent, Ureteral spanning the period from 1993 through 2026. Of these, 9 are classified as death reports, 1,591 as injury reports, and 3,951 as malfunction reports under FDA adverse-event categorization rules. Report counts do not by themselves indicate a device is unsafe — widely used devices and longer market histories naturally generate larger raw counts, so proportional and comparative reads are more informative than totals alone.

The adverse-event profile breaks down across 5 distinct event types and 13 reported patient-outcome categories, giving a multi-dimensional view that goes beyond a single headline number. A total of 20 distinct product-problem codes appear in the reports, with Break topping the list at 1,063 reports. Reports are associated with 10 different manufacturers in the MAUDE record, reflecting both OEMs and repackagers of this device category.

Annual reporting volume is tracked across 34 years of MAUDE data, with the peak single-year volume reaching 691 reports — trend shape often reflects changes in device adoption, reporting rules, or FDA enforcement focus rather than underlying device behavior alone. Events are documented across 13 reported care-setting categories (hospital, home, ambulatory surgery center, etc.). All figures reflect the openFDA MAUDE snapshot last refreshed on . This page is informational and is not medical advice — discuss device-safety questions with your healthcare provider.

5,594
Total Reports
9
Death Reports
1,591
Injury Reports
3,951
Malfunctions

Event Types

Malfunction 3,951 (70.6%)
Injury 1,591 (28.4%)
Other 30 (0.5%)
13 (0.2%)
Death 9 (0.2%)

Patient Outcomes

2,930 (50.6%)
Other 1,342 (23.2%)
Required Intervention 1,136 (19.6%)
Hospitalization 142 (2.5%)
R 135 (2.3%)
H 34 (0.6%)
O 29 (0.5%)
Life Threatening 18 (0.3%)
Death 10 (0.2%)
L 7 (0.1%)
Disability 7 (0.1%)
S 4 (0.1%)
Congenital Anomaly 1 (0.0%)

Top Product Problems

Break 1,063
Material Fragmentation 572
Calcified 374
Adverse Event Without Identified Device or Use Problem 360
Difficult to Remove 256
Material Split, Cut or Torn 222
Difficult to Advance 186
Detachment of Device or Device Component 177
Material Deformation 176
Migration 167
Material Separation 155
Deformation Due to Compressive Stress 148
Patient Device Interaction Problem 110
Biocompatibility 99
Fracture 91
Device Damaged Prior to Use 63
Material Twisted/Bent 57
Wrong Label 54
Unsealed Device Packaging 43
Device Dislodged or Dislocated 40

Yearly Trend

93
1993: 1
94
1994: 3
95
1995: 6
96
1996: 22
97
1997: 16
98
1998: 22
99
1999: 26
00
2000: 11
01
2001: 10
02
2002: 16
03
2003: 18
04
2004: 22
05
2005: 58
06
2006: 81
07
2007: 43
08
2008: 76
09
2009: 123
10
2010: 78
11
2011: 95
12
2012: 131
13
2013: 82
14
2014: 78
15
2015: 130
16
2016: 182
17
2017: 265
18
2018: 277
19
2019: 261
20
2020: 352
21
2021: 531
22
2022: 559
23
2023: 691
24
2024: 603
25
2025: 636
26
2026: 89

Related Entities for Stent, Ureteral

Event Locations

3,407 (60.9%)
I 1,337 (23.9%)
HOSPITAL 761 (13.6%)
NO INFORMATION 38 (0.7%)
OTHER 14 (0.3%)
AMBULATORY SURGICAL FACILITY 8 (0.1%)
HOME 7 (0.1%)
NOT APPLICABLE 5 (0.1%)
INVALID DATA 4 (0.1%)
OUTPATIENT DIAGNOSTIC FACILITY 4 (0.1%)
OUTPATIENT TREATMENT FACILITY 4 (0.1%)
UNKNOWN 4 (0.1%)
AMBULATORY HEALTH CARE FACILITY 1 (0.0%)

Compare BOSTON SCIENTIFIC CORPORATION vs C.R. BARD, INC. (COVINGTON) -1018233 →

Data Source

FDA Manufacturer and User Facility Device Experience (MAUDE) database via the openFDA API. Reports are submitted by manufacturers, healthcare facilities, and patients. Report counts do not indicate a device is unsafe — higher-use devices naturally generate more reports.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the FDA MAUDE database. Consult a qualified professional before making decisions based on this data.